HKU Scholars Hub: Browsing DSpace

Browsing "Department of Psychiatry" by Author nordentoft, m

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 19 of 19

	Title	Author(s)	Issue Date
	Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes Journal:Schizophrenia Research	Youn, S Phillips, LJ Amminger, GP Berger, G Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C McGorry, PD Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, S Yuen, HP Yung, AR Nelson, B	2020
	Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial Journal:Schizophrenia Research	Mallawaarachchi, SR Amminger, GP Farhall, J Bolt, LK Nelson, B Yuen, HP McGorry, PD Markulev, C Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Allott, KA	2020
	Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis Journal:JAMA Psychiatry	Correll, CU Galling, B Pawar, A Krivko, A Bonetto, C Ruggeri, M Craig, TJ Nordentoft, M Srihari, VH Guloksuz, S Hui, CLM Chen, EYH Valencia, M Juarez, F Robinson, DG Schooler, NR Brunette, MF Mueser, KT Rosenheck, RA Marcy, P Addington, J Estroff, SE Robinson, J Penn, D Severe, JB Kane, JM	2018
	Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people Journal:Schizophrenia Research	Alqarni, A Mitchell, TW McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Amminger, GP Meyer, BJ	2020
	Developing and Implementing Tools for Prevention and Early Intervention Book:Youth Mental Health: A Paradigm for Prevention and Early Intervention	Torous, J Chanen, AM Chen, EYH Do, KQ Heinssen, RK McGorry, PD Nordentoft, M Schoenbaum, M Srihari, VH Verma, SK	2020
	Distress related to attenuated psychotic symptoms: Static and dynamic association with transition to psychosis, non-remission and transdiagnostic symptomatology in clinical high-risk patients in an international intervention trial Journal:Schizophrenia Bulletin Open	Nelson, B Yuen, HP Amminger, GP Berger, G Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C Mossaheb, N Nieman, DH Nordentoft, M Polari, A Riecher-Rössler, A Schäfe, MR Schlögelhofer, M Smesny, S Tedja, A Thompson, A Verma, S Yung, AR McGorry, PD	2020
	Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk? Journal:Schizophrenia Research	Hadar, H Zhang, H Phillips, LJ Amminger, GP Berger, GE Chen, EYH de Haan, L Hartmann, JA Hickie, IB Lavoie, S Markulev, C McGorry, PD Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, S Yuen, HP Yung, AR Nelson, B	2020
	Early intervention services in psychosis: from evidence to wide implementation Journal:Early Intervention in Psychiatry	Csillag, C Nordentoft, M Mizuno, M Jones, PB Killackey, E Taylor, M Chen, EYH Kane, J McDaid, D	2016
	How mental health care should change as a consequence of the COVID-19 pandemic Journal:The Lancet Psychiatry	Moreno, C Wykes, T Galderisi, S Nordentoft, M Crossley, N Jones, N Cannon, M Correll, CU Byrne, L Carr, S Chen, EYH Gorwood, P Johnson, S Kärkkäinen, H Krystal, JH Lee, J Lieberman, J López-Jaramillo, C Männikkö, M Phillips, MR Uchida, H Vieta, E Vita, A Arango, C	2020
	International clinical practice guidelines for early psychosis Journal:British Journal of Psychiatry	Addington, J Amminger, GP Barbato, A Catts, S Chen, E Chhim, S Chong, SA Cullberg, J Edwards, J Grosso, L Louzã, M Hambrecht, M Keshavan, M Johannessen, JO Johnson, DL Lewis, S Lieberman, J Macewan, W Malla, A May, R Mcglashan, TH Mcgorry, P Merlo, MG Nordentoft, M Nightingale, S Perkins, D Thara, R Yamamoto, K Yung, A	2005
	Intervention in individuals at ultra-high risk for psychosis: A review and future directions Journal:Journal of Clinical Psychiatry	Mcgorry, PD Nelson, B Amminger, GP Bechdolf, A Francey, SM Berger, G RiecherRössler, A Klosterkötter, J Ruhrmann, S SchultzeLutter, F Nordentoft, M Hickie, I Mcguire, P Berk, M Chen, EYH Keshavan, MS Yung, AR	2009
	Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial Journal:Schizophrenia Research	Bolt, LK Amminger, GP Farhall, J McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Allott, KA	2019
	Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis Journal:Early Intervention in Psychiatry	McLaverty, A Allott, KA Berger, M Hester, R McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher‐Rössler, A Verma, S Thompson, A Yung, AR Amminger, GP	2020
	Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis Journal:Psychotherapy and Psychosomatics	Hartmann, JA McGorry, P Schmidt, S Amminger, P Yuen, HP Markuley, C Berger, GE Chen, EYH de Haan, L Hickie, IB Lavoie, S McHugh, MJ Mossaheb, N Nieman, DH Nordentoft, M Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, SK Yung, A Nelson, B	2017
	Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial Journal:Frontiers in Psychiatry	Berger, M Nelson, B Markulev, C Yuen, HP Schäfer, MR Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Mitchell, TW Meyer, BJ Thompson, A Yung, AR McGorry, PD Amminger, GP	2019
	Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis Journal:Schizophrenia Research	Alqarni, A Mitchell, TW McGorry, PD Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH Haan, L Nieman, DH Nordentoft, M Riecher-Rössler, A Verma, S Thompson, A Yung, AR Meyer, BJ Amminger, GP	2020
	The Identification of Clinical Trajectories in the Ultra High Risk for Psychosis Population Journal:Early Intervention in Psychiatry	Polari, A Lavoie, S Yuen, HP Amminger, P Berger, G Nieman, D Chen, EYH deHaan, L Nordentoft, M Riecher-Rössler, A McGorry, P Nelson, B	2016
	The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis Journal:Biological Psychiatry	Amminger, GP Nelson, B Markulev, C Yuen, HP Schäfer, MR Berger, M Mossaheb, N Schlögelhofer, M Smesny, S Hickie, IB Berger, GE Chen, EYH de Haan, L Nieman, DH Nordentoft, M Riecher-Rössler,, A Verma, S Thompson, A Yung, AR McGorry, PD	2020
	Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial Journal:Behaviour Research and Therapy	Hartmann, JA Schmidt, SJ McGorry, PD Berger, M Berger, GE Chen, EYH de Haan, L Hickie, IB Lavoie, S Markule, C Mossaheb, N Nieman, DH Nordentoft, M Polari, A Riecher-Rössler, A Schäfer, MR Schlögelhofer, M Smesny, S Thompson, A Verma, SK Yuen, HP Yung, AR Amminger, GP Nelson, B	2020

Showing results 1 to 19 of 19